Concentra Group Holdings Parent, Inc.
HealthcareNYSE:CON · New York Stock Exchange
+$0.89 today
Vol 1.13M · Avg 0.80M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
43.9%
avg 27.4%
ROIC
57.6%
avg 17.3%
ROA
5.7%
avg 5.4%
Analysis
ROIC is currently the strongest return metric at 57.6% versus its period average of 17.3%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
William Keith Newton | Chief Executive Officer & Director | $3.04M | — | 63 | $393,750.00 | 0.31% |
Matthew T. DiCanio | President & Chief Financial Officer | $1.78M | — | 43 | $342,292.00 | 0.27% |
Giovanni Gallara | Executive Vice President & Chief Clinical Services Officer | $1.38M | — | 51 | $113,437.00 | 0.09% |
Michael A. Kosuth | Executive Vice President & Chief Operating Officer of East | $1.36M | — | 68 | $76,163.00 | 0.06% |
Su Zan Nelson | Executive Vice President & Chief Accounting Officer | $1.32M | — | 62 | $114,097.00 | 0.09% |
John A. deLorimier | Executive Vice President and Chief Information & Technology Officer | $1.15M | — | 66 | $113,551.00 | 0.09% |
Timothy F. Ryan | Executive Vice President & Chief Legal Counsel | $1.15M | — | 65 | $114,097.00 | 0.09% |
John R. Anderson FACOEM | Executive Vice President & Chief Medical Officer | $1.15M | — | 76 | $114,097.00 | 0.09% |
Danielle Kendall | Executive Vice President & Chief People Officer | — | — | 57 | $76,065.00 | 0.06% |
Thomas A. Devasia | Executive Vice President and Chief Marketing & Innovation Officer | — | — | 56 | $113,551.00 | 0.09% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
2
$6.50M
Net Sentiment
$6.50M
Net selling
Most Active
ORTENZIO ROBERT A
2 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | ORTENZIO ROBERT A Indirect | Sell | 130.0K | $25.00 | $3,250,026.00 | |
| May 8, 2026 | ORTENZIO ROBERT A Indirect | Sell | 130.0K | $25.00 | $3,250,000.00 |
Analysis
Insiders reported 0 buys worth $0.00 and 2 sells worth $6.50M over the last 12 months. That adds up to net selling of $6.50M. ORTENZIO ROBERT A was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -0.5% | +13.4% (3yr)3 analysts |
| Revenue | N/A | N/A | +7.9% | +6.7% (3yr)4 analysts |
| Net Income | N/A | N/A | +1.2% | +12.1% (3yr)4 analysts |
| EBIT | N/A | N/A | +100.7% | -41.5% (3yr)4 analysts |
Analysis
Recent growth has been strongest in EBIT at +100.7% over three years. Forward estimates point to EPS at +13.4% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Haemonetics Corporation
NYSE:HAE
$3.55B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
Premier, Inc.
PINC
$2.34B
Prestige Consumer Healthcare Inc.
NYSE:PBH
$2.27B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.02B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.91B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
Who manages CON?
Concentra Group Holdings Parent, Inc. (CON) lists 10 active executives. The top listed executive is Matthew T. DiCanio, President & Chief Financial Officer.
Are CON insiders buying or selling?
Recent insider activity shows net selling of $8.33M.
Explore More
Continue the stock analysis
Jump to another research area for this company.